1. The experimental antitumour properties of three congeners of the acridinyl methanesulphonanilide (AMSA) series;Cain;Eur J Cancer,1974
2. Current status of amsacrine combination chemotherapy programs in acute leukaemia;Arlin;Cancer Treat Rep,1983
3. Synthesis, antitumor activity and DNA binding properties of a new derivative of amsacrine N,5-dimethyl-9-((2-methoxy-4-methylsulfonylamino)-phenylamino)-4-acridinecarboxamide;Baguley;Cancer Res,1984
4. A multicenter assessment of the experimental antitumor activity of the amsacrine analog, CI-921;Leopold;J Natl Cancer Inst,1987
5. The clinical pharmacokinetics of N-5-dimethyl-9[(2-methoxy-4-methyl-sulfonylamino)phenylamino]-4-acridinecarboxamide (CI-921) in a phase I trial;Paxton;Cancer Chem Pharm,1988